Medicine and Dentistry
Cohort Analysis
100%
Hip Fracture
66%
Randomized Controlled Trial
40%
Tranexamic Acid
33%
Blood Transfusion
33%
Femur Intertrochanteric Fracture
33%
Conservative Treatment
33%
Femur Fracture
33%
Reoperation
33%
Patient-Reported Outcome
33%
Internal Fixation
33%
Implant
20%
Body Mass Index
20%
Erythrocyte Transfusion
20%
Humerus Shaft Fracture
20%
Nonunion
20%
Thromboembolism
13%
Injury
13%
Nerve Injury
13%
Infection
13%
Clinical Guideline
13%
Koji
11%
Hazard Ratio
10%
Surgeon
6%
Surgical Revision
6%
Proportional Hazards Model
6%
Cardiovascular Disease
6%
Fracture Treatment
6%
Disabilities of the Arm, Shoulder and Hand (Score)
6%
Arm
6%
Orthopedics
6%
Blood Vessel Injury
6%
Periprosthetic Fracture
6%
Range of Motion
6%
Subgroup Analysis
6%
Constant Murley (Score)
6%
Charlson Comorbidity Index
6%
Drug Therapy
6%
Surgical Procedure
6%
Elbow
6%
Neutralization
6%
Prosthesis Loosening
6%
Nursing and Health Professions
Hip Fracture
100%
Cohort Analysis
66%
Perioperative
36%
Tranexamic Acid
33%
Nottingham Health Profile
33%
Practice Guideline
33%
Methadone
33%
Blood Transfusion
33%
Dose Calculation
33%
Wrist Fracture
25%
Confidence Interval
20%
Erythrocyte Transfusion
20%
Convergent Validity
16%
Correlation Coefficient
16%
Cronbach Alpha Coefficient
16%
Thromboembolism
13%
Clinical Guideline
13%
Hazard Ratio
10%
Elderly Patient
9%
Analgesia
9%
Internal Consistency
8%
Test Retest Reliability
8%
Content Validity
8%
Injury
8%
Social Isolation
8%
Disease
8%
Charlson Comorbidity Index
6%
Drug Therapy
6%
Proportional Hazards Model
6%
External Validity
6%
Body Mass
6%
Pharmacology, Toxicology and Pharmaceutical Science
Hip Fracture
66%
Cohort Study
33%
Tranexamic Acid
33%
Methadone
33%
Maximum Tolerated Dose
23%
Thromboembolism
13%
